Comparative trichoscopic analysis of efficacy of combination therapy versus monotherapy of platelet rich plasma and topical minoxidil in the treatment of androgenetic alopecia
DOI:
https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20241722Keywords:
Androgenetic alopecia, PRP, Minoxidil, TrichoscopyAbstract
Background: Hair is a pivotal facet of physical visage and cultural identity. Since time immemorial hair has been considered as a sign of vitality, beauty and health. Hair loss complaint is encountered by at least 50% of men and women in their lives. Androgenetic Alopecia is one of the most common causes of hair loss among youth which often leads to psychological stress. This underscores the need for early detection and treatment of androgenetic alopecia. Hence a comparative trichoscopic analysis of the efficacy of combination therapy vs monotherapy of platelet rich plasma (PRP) and topical minoxidil in the treatment of androgenetic alopecia was done.
Methods: Sixty untreated cases of androgenetic alopecia were enrolled in this randomized prospective interventional study. Patients were randomly allotted into three groups. Group I (PRP with minoxidil), Group II (Minoxidil), Group III (PRP). Patients were assessed by trichoscopic evaluation, clinical photographs, physician assessment and patient self-assessment at the end of three months and six months of treatment.
Results: Among group 1 (PRP+Minoxidil), a total of 55% of patients had improvement in the grade of alopecia while in group 2 (Minoxidil), 25% of patients had improvement in the grade and 40% of patients had improvement in group 3(PRP). By trichoscopic analysis, 58.6% of patients had improvement in group 1, 36.5% of patients had improvement in group 2 and 44.025% of patients improved in group 3.
Conclusions: Combination therapy with both PRP+Minoxidil shows significant results when compared to individual therapies which was confirmed by trichoscopic analysis.
Metrics
References
Kaliyadan F, Nambiar A, Vijayaraghavan S. Androgenetic alopecia: An update. Indian J Dermatol Venereol Leprol. 2013;79:613-25.
Salman KE, Altunay IK, Kucukunal NA, Cerman AA. Frequency, severity and related factors of androgenetic alopecia in dermatology outpatient clinic: hospital-based cross-sectional study in Turkey. An Bras Dermatol. 2017;92(1):35-40.
Shankar DK, Chakravarthi M, Shilpakar R. Male androgenetic alopecia: Population-based study in 1,005 subjects. Int J Trichol. 2009;1:131-3.
Sperling LC, Sinclair RD, El Shabrawi-Caelen L. Alopecia. Bolognia textbook of Dermatotology. 4th edition. 2012;1(69):1166.
Devjani S, Ezemma O, Kelley KJ, Stratton E, Senna M. Androgenetic Alopecia: Therapy Update. Drugs. 2023;83(8):701-15.
Bouhanna P. Androgenetic Alopecia: Combining Medical and Surgical Treatments. Dermatol Surg. 2003;29(11):1130-4.
Messenger AG, Sinclair RD, Farrant P, De Berker DAR. Acquired disorders of hair. Rooks Textbook Dermatol. 9th edition. 2016: 2278.
Ankad B, Jaju PA, Khare S. Trichoscopy. IADVL Textbook of Dermatology. 5th edition. 2016;2. 48:1662.
Verma K, Tegta GR, Verma G, Gupta M, Negi A, Sharma R. A Study to Compare the Efficacy of Platelet-rich Plasma and Minoxidil Therapy for the Treatment of Androgenetic Alopecia. Int J Trichol. 2019;11(2):68-79.
Elena EP, Irina OS. Combination therapy with platelet-rich plasma and minoxidil leads to better clinical results than monotherapy with these methods in men with androgenetic alopecia. Int J Trichol. 2022;14(1): 1-7.
Khatu SS, More YE, Gokhale NR, Chavhan DC, Bendsure N. Platelet-rich plasma in Androgenic alopecia: Myth or an effective tool. J Cutan Aesthet Surg. 2014;7:107-10.
Gkini MA, Kouskoukis AE, Tripsianis G, Rigopoulos D, Kouskoukis K. Study of platelet-rich plasma injections in the treatment of androgenetic alopecia through one- year period. J Cutan Aesthet Surg. 2014;7:213-9.
Downloads
Published
How to Cite
Issue
Section
